GPC-100

GPCR Therapeutics, Inc. · Phase 2 active Small molecule

At a glance

Generic name	GPC-100
Sponsor	GPCR Therapeutics, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant (PHASE2)
Study to Assess the Efficacy of Cognitex (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GPC-100 CI brief — competitive landscape report
GPC-100 updates RSS · CI watch RSS
GPCR Therapeutics, Inc. portfolio CI